IBM’s, Data

IBM’s Data Dilemma: Why 91% of Executives Are Flying Blind and How an $11 Billion Bet Aims to Fix It

17.06.2026 - 07:52:52 | boerse-global.de

IBM research reveals an 'Accountability Gap' as most business leaders lack AI vendor oversight; the company promotes AI Sovereignty via hybrid cloud and major acquisitions.

IBM Study: 91% of Executives Can't Track AI Vendor Dependencies
IBM’s - IBM’s Data Dilemma: Why 91% of Executives Are Flying Blind and How an $11 Billion Bet Aims to Fix It 17.06.2026 - Bild: über boerse-global.de

A sweeping new IBM study has laid bare a troubling reality for the enterprise world: the vast majority of business leaders have little grasp of their own reliance on artificial intelligence providers. The research, conducted by the IBM Institute for Business Value across 1,000 executives in 16 countries and 17 industries, found that 91% of managers admit they cannot fully track their dependencies on AI vendors, models, and infrastructure. Even more telling, 71% said switching AI providers would be difficult. IBM brands this the “Accountability Gap”—the widening chasm between the responsibility executives bear for AI outcomes and the control they actually exercise.

The study is far from an academic exercise. Big Blue is using the findings to push its own prescription for the problem: a concept it calls “AI Sovereignty,” which champions running AI workloads inside controlled, open environments rather than locking into proprietary ecosystems. The centerpiece of that vision is Red Hat OpenShift and the broader hybrid-cloud architecture. Complementing this push, IBM Japan and Fujitsu have deepened their partnership to modernise legacy systems, migrating old programming languages into hybrid cloud environments, while the IBM-owned Apptio has rolled out new “Conversational Insights” tools designed to help firms gain better command of their sprawling IT costs.

Yet the strategic narrative extends well beyond consulting services and cost management. Over the past year, IBM has reshaped its portfolio through two blockbuster acquisitions. The first, HashiCorp, closed roughly 12 months ago, its developer tooling now being fused with OpenShift. Then came the spring of 2026, when the company announced the $11 billion purchase of Confluent, a data-streaming platform used by nearly half of the Fortune 500 for real-time operations. That deal is meant to address a glaring bottleneck: according to IBM’s own data, roughly 90% of corporate data generated in 2022 remains unstructured, and large language models currently capture just 1% of it. Only 11% of organisations have deployed AI agents in production today. By combining Confluent’s real-time data fabric with its watsonx Orchestrate software, IBM wants to give enterprises the ability to steer existing AI agents efficiently rather than building new ones from scratch.

Should investors sell immediately? Or is it worth buying IBM?

The market, however, has greeted the transformation with a mix of enthusiasm and hesitation. IBM shares closed at €233.30, hovering almost exactly at their 200-day moving average. Over the past month, the stock has rallied 22% from a 52-week low of €181.32 hit in May, but it remains roughly 6% lower year to date. The relative strength index sits at a neutral 51.9, and the annualised 30-day volatility has spiked to 66%—an unusually high figure for a blue-chip technology company. That volatility reflects the tug-of-war between bulls who see a revitalised IBM and bears who question whether the new strategy can generate sustainable growth.

The first-quarter 2026 earnings offered some ammunition for the optimists. Software and infrastructure revenue grew at a double-digit clip, margins expanded, and free cash flow improved. Red Hat OpenShift notched annual recurring revenue of $2 billion, while the broader software business reported $24.6 billion in recurring revenue, up 10% from a year earlier. Chief Executive Arvind Krishna has framed artificial intelligence as an enduring tailwind, noting that IBM’s platform-agnostic approach—working across different infrastructures and models—avoids the risk of betting on a single winner.

Still, the stock has fallen roughly 20% from its 52-week high of nearly €293, and the average analyst price target of about €251 implies a modest upside of only 7.5%. The disconnect between strategic ambition and market valuation is stark. IBM must now convert its AI and data-platform narrative into consistent software subscription growth, especially as its traditional mainframe cycle—a major driver of recent infrastructure revenue—is inherently temporary. The durability of the new IBM hinges on whether its tools become indispensable to large corporate customers. For now, the gap between story and stock price is precisely what makes the equity so closely watched.

Ad

IBM Stock: New Analysis - 17 June

Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated IBM analysis...

en | US4592001014 | IBM’S | boerse | 69559512 |